Michael Davidson's Insider Trades & SAST Disclosures

Michael Davidson's most recent trade in Tenax Therapeutics Inc was a trade of 80,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 1, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Tenax Therapeutics Inc
Michael Davidson Harvey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2025 80,000 80,000 - - Stock Option (right to buy)
BioAge Labs Inc.
Michael Harvey Davidson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2025 22,000 22,000 - - Stock Option (Right to Buy)
NewAmsterdam Pharma Compan...
Michael Harvey Davidson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Mar 2025 38,394 402,699 - 0 Ordinary Shares
NewAmsterdam Pharma Compan...
Michael Harvey Davidson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Mar 2025 38,394 0 - - Restricted Stock Unit
NewAmsterdam Pharma Compan...
Michael Harvey Davidson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2025 38,394 38,394 - - Restricted Stock Unit
NewAmsterdam Pharma Compan...
Michael Harvey Davidson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2025 30,992 364,305 - 0 Ordinary Shares
NewAmsterdam Pharma Compan...
Michael Harvey Davidson Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Mar 2025 12,258 390,441 - - Ordinary Shares
NewAmsterdam Pharma Compan...
Michael Harvey Davidson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 670,467 670,467 - - Option (right to buy)
NewAmsterdam Pharma Compan...
Michael Harvey Davidson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 123,529 123,529 - - Ordinary Shares
Silence Therapeutics Plc -...
Michael Harvey Davidson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 48,000 48,000 - - Share Option (Right to Buy)
Tenax Therapeutics Inc
Davidson Michael Harvey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2024 100,000 100,000 - - Stock Option (right to buy)
NewAmsterdam Pharma Compan...
Michael Harvey Davidson Director, Chief Executive Officer Gift of securities by or to the insider at price $ 0.00 per share. 09 Oct 2024 15,000 85,000 - - Warrant (right to buy)
NewAmsterdam Pharma Compan...
Michael Harvey Davidson Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 16.27 per share. 20 Aug 2024 5,000 209,784 - 16.3 81,350 Ordinary Shares
Tenax Therapeutics Inc
Michael Harvey Davidson Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 08 Aug 2024 47,500 47,500 - - Pre-Funded Warrant
Tenax Therapeutics Inc
Michael Harvey Davidson Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 08 Aug 2024 25,000 25,000 - - Warrant
Tenax Therapeutics Inc
Michael Harvey Davidson Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 08 Aug 2024 2,500 2,881 (0%) 0% - Common Stock
NewAmsterdam Pharma Compan...
Michael Harvey Davidson Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 17.26 per share. 20 Jun 2024 5,000 204,784 - 17.3 86,309 Ordinary Shares
BioAge Labs Inc.
Michael Harvey Davidson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2024 33,986 33,986 - - Stock Option (Right to Buy)
BioAge Labs Inc.
Michael Harvey Davidson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2024 15,000 15,000 - - Stock Option (Right to Buy)
NewAmsterdam Pharma Compan...
Davidson Harvey Michael Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 1,039,939 1,039,939 - - Option (right to buy)
Lisata Therapeutics Inc
Michael Harvey Davidson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2022 65,430 209,753 (1%) 0% 0 Common Stock
Lisata Therapeutics Inc
Michael Harvey Davidson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2021 37,735 144,323 (1%) 0% 0 Common Stock
Minerva Neurosciences Inc
Michael Davidson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Oct 2020 85,000 85,000 - - Employee Stock Option (right to buy)
Lisata Therapeutics Inc
Michael H. Davidson Director Purchase of securities on an exchange or from another person at price $ 1.80 per share. 09 Sep 2020 55,525 106,588 (1%) 0% 1.8 99,945 Common Stock
Lisata Therapeutics Inc
Michael H. Davidson Director Grant, award, or other acquisition of securities at price $ 2.35 per share. 28 Jul 2020 51,063 51,063 (0%) 0% 2.3 119,998 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades